PDS Biotechnology PDSB
NASDAQ PDSB
$0.74 -0.02 (-3.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Cash from Restructuring (2019 - 2020)

Updated

PDS Biotechnology (PDSB) reported Cash from Restructuring of -$498,185 for FY2020, compared with -$1.57 million in FY2019.

Analysis

PDS Biotechnology (PDSB) Cash from Restructuring (2019 - 2020) Analysis & Trends

  • According to Business Quant data, Cash from Restructuring came in at -$1.57 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 PDS Biotechnology 43.06 Mn 43.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -126,862.00
Jun 30, 2020 -143,025.00
Mar 31, 2020 -228,298.00
Dec 31, 2019 -360,147.00
Sep 30, 2019 -425,543.00
Jun 30, 2019 -664,721.00
Mar 31, 2019 -121,675.00
API Access

PDS Biotechnology Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=PDSB&period=max&api_key=YOUR_API_KEY